The strategies of a innovation-driven CMO may be different than a capacity-driven CMO.
Manufacturers and regulatory authorities seek coordinated lifecycle management policies.
Innovations in electrophoresis and chromatography upstream of protein characterization can accelerate research.
Agilent Technologies announces plans to build a new oligo manufacturing facility in Colorado that will double current capacity.
CMOs are working hard to improve performance by investigating new technologies for filtration and purification.
EAG Laboratories announces new company identity and intent to expand testing, analysis, and characterization capabilities across multiple markets.
The Parenteral Drug Association develops program to address barriers to implementation of postapproval changes.
FDA issued a warning letter to College Pharmacy for multiple violations.